Abstracts tagged "Access to care"

Abstract Number: 266 • 2019 ACR/ARP Annual Meeting
Measuring Advanced/Extended Practice Roles in Arthritis and Musculoskeletal Care in Canada: Stand up and Be Counted Too (2)!
Katie Lundon¹, Taucha Inrig ², Morag Paton ¹, Rachel Shupak ², Carol Kennedy ², Mandy McGlynn ³ and Claire Barber ⁴, ¹University of Toronto, Toronto, ²St. Michael's Hospital, Toronto, ON, Canada, ³UHN, Toronto, ⁴University of Calgary, Calgary, Canada
Background/Purpose: Arthritis and musculoskeletal disorders are the most common chronic health conditions in Canada but there is a critical and growing shortage of rheumatologists relative…
Abstract Number: 1118 • 2019 ACR/ARP Annual Meeting
US Community Rheumatologists’ Knowledge and Perceptions of Biosimilar Expanded Indication Approval by Extrapolation
Ting-Chun Yeh¹, Yolaine Jeune-Smith ¹, Eli Phillips ¹, Ajeet Gajra ¹ and Bruce Feinberg ¹, ¹Cardinal Health Specialty Solutions, Dublin, OH
Background/Purpose: To expand treatment options, increase access to life-saving medications, and lower healthcare costs through competition, the US Congress created an abbreviated licensure pathway for…
Abstract Number: 1136 • 2019 ACR/ARP Annual Meeting
Improving Access in an Academic Rheumatology Department by Reducing the No Show Rate
Richard Zamore¹, ¹Hospital of the University of Pennsylvania, Philadelphia, PA
Background/Purpose: No shows are a widespread problem across medical practices, and lead to negative consequences for patients and providers (Mendel 2017). The rheumatology division at…
Abstract Number: 2831 • 2019 ACR/ARP Annual Meeting
Cracks in Your Referral Process? Find Your Sustainable Solution Here
Sheetal Vora¹, Amanda Moyer ², Lynn Kalhagen ², Anna Sherrod ², Thomas Griffin ², Kristen Corcoran ², Sarah Mabus ² and Talia Buitrago ², ¹Atrium Health, Charolotte, ²Atrium Health, Charlotte
Background/Purpose: Early diagnosis for rheumatic conditions is crucial for children to achieve the best functional outcomes. Access to care is difficult due to the volume…
Abstract Number: 2869 • 2019 ACR/ARP Annual Meeting
Access to Care and Diagnostic Delays in Juvenile Dermatomyositis
Jessica Neely ¹, Susan Kim ¹, Hugh Sturrock ² and Julia Shalen², ¹University of California, San Francisco, San Francisco, CA, ²UCSF, San Francisco
Background/Purpose: Factors associated with diagnostic delay in Juvenile Dermatomyositis (JDM) are not known. We hypothesized that limited access to pediatric rheumatologists can lead to delay…
Abstract Number: 275 • 2018 ACR/ARHP Annual Meeting
Health Equity: Access to Rituximab for Patients Comparing Variable Access in a Single Rheumatology Clinic
Raymond Chu¹, Catherine Mallon¹, Jan Willem Cohen Tervaert¹ and Elaine Yacyshyn², ¹University of Alberta, Edmonton, AB, Canada, ²Medicine, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The purpose of our study is to investigate the difference in time to access of rituximab therapy between patients with rheumatoid arthritis (RA) compared…
Abstract Number: 345 • 2018 ACR/ARHP Annual Meeting
Snap Crackle Pop: Healing the Cracks in Our Referral Process, Helping Pediatric Rheumatology Patients Get Care Sooner
Sheetal S. Vora¹, Talia L. Buitrago-Mogollon², Sarah C. Mabus¹, Thomas A. Griffin¹, Anna Sherrod¹, Lynn W. Kalhagen¹ and Emily S. Ogletree¹, ¹Pediatrics, Levine Children's Hospital, Charlotte, NC, ²1000 Blythe Blvd, Atrium Health, Charlotte, NC
Background/Purpose: Early diagnosis for rheumatic conditions is crucial for children to achieve the best functional outcomes. Access to care is difficult due to the volume…
Abstract Number: 560 • 2018 ACR/ARHP Annual Meeting
Impact of Formulary Copayment Change on Treatment Patterns in Rheumatoid Arthritis Patients on Etanercept
Hafiz Oko-osi¹, Machaon Bonafede², Mahdi Gharaibeh¹, Janna Manjelievskaia², Lorena Lopez-Gonzalez², David H. Collier¹ and Bradley S. Stolshek¹, ¹Amgen Inc., Thousand Oaks, CA, ²IBM Watson Health, Cambridge, MA
Background/Purpose: Rheumatoid arthritis (RA) is a chronic disease that requires long-term treatment to improve or maintain disease activity. Tumor necrosis factor inhibitors (TNFi), a…
Abstract Number: 1173 • 2018 ACR/ARHP Annual Meeting
Measuring the Advanced Clinician Practitioner in Arthritis Care (ACPAC) Program Trained Extended Role Practitioner (ERP) Workforce in Canada: A Profile of Practice Settings, Roles and Participation in Models of Arthritis Care in Canada
Katie Lundon¹, Rachel Shupak² and Amanda Pullan³, ¹University of Toronto, Office of Continuing Professional Development, Faculty of Medicine, Toronto, ON, Canada, ²Medicine, St. Michael's Hospital, Toronto, ON, Canada, ³Office of Continuing Professional Development, Faculty of Medicine, Toronto, ON, Canada
Background/Purpose: 1. To measure and map the ACPAC ERP workforce in Canada. 2. To present a snapshot of general practice characteristics relating to the ACPAC-trained…
Abstract Number: 2187 • 2018 ACR/ARHP Annual Meeting
Specialist Link Telephone Advice Cost Effectively Enhances Rheumatology Patient Care in Alberta, Canada
Yolanda Martens-Vanhilst¹, Dianne P. Mosher², Linda Slocombe¹ and Paul MacMullan³, ¹University of Calgary, Calgary, AB, Canada, ²Med, University of Calgary, Calgary, AB, Canada, ³Medicine, Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: The Calgary zone of Alberta Health Services serves a population of almost 2million Canadians over a wide geographical area and is underserved in terms…
Abstract Number: 2309 • 2018 ACR/ARHP Annual Meeting
Implementation of a Primary Prevention, Population-Based Virtual Osteoporosis Clinic Dramatically Increases the Number of Rural Veterans Receiving Osteoporosis Screening and Treatment
Karla L. Miller¹, Shardool Patel², Grant W. Cannon³ and Zachary L. Anderson², ¹Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ²Salt Lake City VA Medical Center, Salt Lake City, UT, ³Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT
Background/Purpose: The delivery of osteoporosis services is sub-optimal nationally and throughout the Veterans Affairs (VA) healthcare system and particularly poor for rural Veterans. To meet…
Abstract Number: 419 • 2017 ACR/ARHP Annual Meeting
Abatacept Initiation in Chilean Patients with Long Lasting Rheumatoid Arthritis. Hospital Padre Hurtado Experience
Omar Valenzuela¹, María Paz Poblete², Claudia Mardones², Sebastián Ibáñez¹, Katherine Mogollones², Francisco Silva¹ and María José Villar², ¹Rheumatology department, Hospital Padre Hurtado, Santiago, Chile, ²Hospital Padre Hurtado, Santiago, Chile
Background/Purpose: Since the year 2016 Rheumatoid Arthritis (RA) patients in the Chilean public health system can access biologic treatment if they have active disease refractory…
Abstract Number: 882 • 2017 ACR/ARHP Annual Meeting
A New Model of Care for Improving Early Rheumatology Access of Psoriatic Arthritis Patients
Keith Colaco^1,2, Dana Jerome³, Jensen Yeung^4,5, Noah Ivers^6,7,8, Carol Kitai⁷, Chandra Farrer³ and Lihi Eder^1,9, ¹Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, ²Institute of Medical Science, University of Toronto, Toronto, ON, Canada, ³Rheumatology, Women's College Hospital, Toronto, ON, Canada, ⁴Dermatology, Women's College Hospital, Toronto, ON, Canada, ⁵University of Toronto, Toronto, ON, Canada, ⁶Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁷Women's College Hospital, Toronto, ON, Canada, ⁸Family and Community Medicine, University of Toronto, Toronto, ON, Canada, ⁹Medicine, University of Toronto, Toronto, ON, Canada
Background/Purpose: The prevalence of undiagnosed psoriatic arthritis (PsA) in psoriasis patients is high, with delays in diagnosis contributing to poor patient outcomes. We aimed to…
Abstract Number: 1040 • 2017 ACR/ARHP Annual Meeting
Perceptions of US Community Rheumatologists on Biosimilars
Janna Radtchenko, Yolaine Smith, Jonathan Kish and Bruce Feinberg, Specialty Solutions, Cardinal Health, Dallas, TX
Background/Purpose: Biosimilars contain a highly similar version of the active substance of an already approved biologic or “reference product.”1 Regulatory agencies mandate that safety, efficacy,…
Abstract Number: 1051 • 2017 ACR/ARHP Annual Meeting
Telemedicine for Rheumatoid Arthritis in the Alaska Native Population
Elizabeth Ferucci¹, Tammy Choromanski¹, Gretchen Day² and Sarah Freeman³, ¹Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, AK, ²Clinical and Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, ³Alaska Native Tribal Health Consortium, Anchorage, AK
Background/Purpose: Access to a rheumatologist and frequent monitoring of disease activity in rheumatoid arthritis (RA) are associated with higher quality of care and improved outcomes.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].